Table 3.
Burden of inadequately controlled atopic dermatitis
| Outcome | Inadequate control | Controlled | P |
|---|---|---|---|
| Physician‐reported, n/total (%)† | n = 625 | n = 439 | |
| Depression | 383/598 (64.0) | 224/426 (52.6) | 0.0003 |
| Anxiety | 445/605 (73.6) | 293/429 (68.3) | 0.0696 |
| Stress | 469/609 (77.0) | 292/431 (67.7) | 0.0011 |
| Itch interference with daily living | 293/609 (48.1) | 121/433 (27.9) | <0.0001 |
| Sleep disturbance interfering with daily living | 141/593 (23.8) | 36/425 (8.5) | <0.0001 |
| Patient‐reported | n = 398 | n = 257 | |
| POEM score | 11.7 ± 6.8 (n = 382) | 8.4 ± 5.8 (n = 252) | <0.0001 |
| DLQI score | 8.1 ± 6.6 (n = 366) | 5.6 ± 5.0 (n = 242) | <0.0001 |
| WPAI:SHP Overall Work Impairment, %‡ | 22.8 ± 22.2 (n = 243) | 18.4 ± 19.9 (n = 164) | 0.0398 |
†Reflects actual number of patients because data were missing for some outcomes. ‡Among employed patients who completed the Work Productivity and Impairment Index for Specific Health Problem (WPAI:SHP). Data are presented as mean ± standard deviation unless otherwise stated. DLQI, Dermatology Life Quality Index; POEM, Patient‐Oriented Eczema Measure.